SCHEMBL10080422

SCHEMBL10080422

CCn1c(-c2ccc(OC)cc2)nc2ccccc21

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.80
ALDH1A1 P00352 9/20 0.80
LMNA P02545 4/20 0.80
NPSR1 Q6W5P4 3/20 0.80
TSHR P16473 2/20 0.80
GAA P10253 2/20 0.80
SMN1; SMN2 Q16637 7/20 0.77
MAPT P10636 7/20 0.77
TP53 P04637 6/20 0.77
NPC1 O15118 3/20 0.77
RAB9A P51151 3/20 0.77
HTT P42858 6/20 0.75
L3MBTL1 Q9Y468 2/20 0.75
CNR2 P34972 1/20 0.75
HPGD P15428 5/20 0.73
HSD17B10 Q99714 3/20 0.72
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
HIF1A Q16665 1/20 0.70
CYP1A2 P05177 2/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30496676 0.89 KDM4E (1.00) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL5582025 0.86 ALDH1A1 (1.00) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL22819342 0.85 KDM4E (0.73) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL19275978 0.84 KDM4E (0.77) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL5009162 0.84 KDM4E (0.77) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL10061946 0.83 KDM4E (1.00) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL10061943 0.83 KDM4E (0.70) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL3431636 0.83 ALDH1A1 (0.79) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL10443668 0.82 ALDH1A1 (0.92) KDM4EALDH1A1LMNANPSR1TSHR
SCHEMBL28141462 0.82 KDM4E (0.75) KDM4EALDH1A1LMNANPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022265-A1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM BERG-SCHULTZ KATJA (CH) 2012-01-26 US disclosed
US-20100256082-A1 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties VIAMET PHARMACEUTICALS, INC. (US) 2010-10-07 US disclosed
US-20080089852-A1 copolymeric (meth)acrylic esters or (meth)acrylic amides containing a chromophore having uv absorption properties selected from aminobenzoates, camphors, cinnamates, benzophenones, benzalmalonic esters, esters of 2-(4-ethoxy anilinomethylene)propandioic, imidazoles, acrylates, phenyl-benzimidazoles DSM IP ASSETS B.V. (NL) 2008-04-17 US disclosed
US-20070190325-A1 Microcapsules with uv filter activity and process for producing them DSM IP ASSETS B.V. (NL) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256082-A1 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties MMEL1, MPI, METAP1 KDM4E 1756/4885ALDH1A1 322/4885LMNA 4580/4885
US-20120022265-A1 MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM UACA, UROD, UMPS KDM4E 3121/4885ALDH1A1 3001/4885LMNA 472/4885
US-20070190325-A1 Microcapsules with uv filter activity and process for producing them UACA, UROD, UMPS KDM4E 3121/4885ALDH1A1 3001/4885LMNA 472/4885
US-20080089852-A1 copolymeric (meth)acrylic esters or (meth)acrylic amides containing a chromophore having uv absorption properties selected from aminobenzoates, camphors, cinnamates, benzophenones, benzalmalonic esters, esters of 2-(4-ethoxy anilinomethylene)propandioic, imidazoles, acrylates, phenyl-benzimidazoles PAH, ACMSD, AAAS KDM4E 537/4885ALDH1A1 65/4885LMNA 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.